Molecular Imaging in Genomic Medicine

Molecular imaging is the result of advances in the fields of molecular biology and imaging technology and has become an increasingly important tool in the discovery and understanding of a wide range of pathophysiologic processes, ranging from genetic disorders to malignant conditions. The advancement in molecular pathology techniques has enabled us to study the complex genotype of disease entities and how it impacts their behaviour and natural history. Image-guided genomic medicine utilises methodologies to integrate genomic and radiologic data to develop insights into the genotype–phenotype relationship, which in turn can guide medical decision-making and treatment planning. Key Concepts Molecular imaging comprises the visualisation, characterisation and measurement of biological processes at the molecular and cellular levels, which can synergise with genomic medicine to enhance our understanding of disease processes. Reporter gene imaging entails encoding proteins that can be rapidly and sensitively assayed as surrogate markers when fused with regulatory regions of the gene of interest as a means of indirectly monitoring molecular basis of diseases. Optical imaging is based on the principle of detecting light in living organisms that reflect molecular processes; types include bioluminescence and fluorescence imaging. ImmunoPET is based on combining the PET with monoclonal antibodies raised against a tumoural antigen. Functional MRI uses the MRI technology to provide a means of measuring brain activity by detecting changes associated with blood flow as a phenotype that can be correlated with genotypic data. Radiomics/imaging genomics leverage machine learning technology to process large data sets acquired through imaging and genomic biomarker extraction and provide valuable insights into pathophysiology and personalised disease management. Gene therapeutics is another area where molecular imaging can be valuable in therapy monitoring and response assessment. Keywords: molecular; imaging; genomic; reporter; gene; PET; MRI; optical

[1]  C. Bailly,et al.  Immuno-PET for Clinical Theranostic Approaches , 2016, International journal of molecular sciences.

[2]  Jesse V Jokerst,et al.  Clinically Approved Nanoparticle Imaging Agents , 2016, The Journal of Nuclear Medicine.

[3]  F. Mulero,et al.  Targeting MT1-MMP as an ImmunoPET-Based Strategy for Imaging Gliomas , 2016, PloS one.

[4]  Marc C. Huisman,et al.  Immuno-Positron Emission Tomography with Zirconium-89-Labeled Monoclonal Antibodies in Oncology: What Can We Learn from Initial Clinical Trials? , 2016, Front. Pharmacol..

[5]  Lei Zheng Monoclonal Antibodies: Development, Delivery and Applications , 2015 .

[6]  Sharon S. Hori,et al.  Detecting cancers through tumor-activatable minicircles that lead to a detectable blood biomarker , 2015, Proceedings of the National Academy of Sciences.

[7]  Max Wintermark,et al.  Imaging genomic mapping of an invasive MRI phenotype predicts patient outcome and metabolic dysfunction: a TCGA glioma phenotype research group project , 2014, BMC Medical Genomics.

[8]  Rubel Chakravarty,et al.  Nanobody: The “Magic Bullet” for Molecular Imaging? , 2014, Theranostics.

[9]  Steven P. Larson,et al.  Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  Hengyi Rao,et al.  Applications of arterial spin labeled MRI in the brain , 2012, Journal of magnetic resonance imaging : JMRI.

[11]  S. Batra,et al.  Recent trends in antibody-based oncologic imaging. , 2012, Cancer letters.

[12]  A. Wu,et al.  Positive progress in immunoPET--not just a coincidence. , 2010, Cancer biotherapy & radiopharmaceuticals.

[13]  A. K. Tyagi,et al.  Nanoceria-PAN composite-based advanced sorbent material: a major step forward in the field of clinical-grade 68Ge/68Ga generator. , 2010, ACS applied materials & interfaces.

[14]  Anna M Wu,et al.  Antibody vectors for imaging. , 2010, Seminars in nuclear medicine.

[15]  M. Apuzzo,et al.  Molecular imaging, part 1: apertures into the landscape of genomic medicine. , 2010, World neurosurgery.

[16]  H. Hricak,et al.  A New Acycloguanosine-Specific Supermutant of Herpes Simplex Virus Type 1 Thymidine Kinase Suitable for PET Imaging and Suicide Gene Therapy for Potential Use in Patients Treated with Pyrimidine-Based Cytotoxic Drugs , 2008, Journal of Nuclear Medicine.

[17]  Pius August Schubiger,et al.  Molecular imaging with PET. , 2008, Chemical reviews.

[18]  J. Humm,et al.  Preoperative characterisation of clear-cell renal carcinoma using iodine-124-labelled antibody chimeric G250 (124I-cG250) and PET in patients with renal masses: a phase I trial. , 2007, The Lancet. Oncology.

[19]  Sanjiv S Gambhir,et al.  Reporter gene imaging of protein-protein interactions in living subjects. , 2007, Current opinion in biotechnology.

[20]  P. Hudson,et al.  Engineered antibody fragments and the rise of single domains , 2005, Nature Biotechnology.

[21]  R. Mansberg,et al.  Paravertebral infection (phlegmon) demonstrated by FDG dual-head coincidence imaging in a patient with multiple malignancies. , 2005, Clinical nuclear medicine.

[22]  M. Brenner,et al.  Genetic modification of T lymphocytes for adoptive immunotherapy. , 2004, Molecular therapy : the journal of the American Society of Gene Therapy.

[23]  R. Tsien,et al.  Imaging Tri-Fusion Multimodality Reporter Gene Expression in Living Subjects , 2004, Cancer Research.

[24]  S. Gambhir Molecular imaging of cancer with positron emission tomography , 2002, Nature Reviews Cancer.

[25]  M. Egan,et al.  Serotonin Transporter Genetic Variation and the Response of the Human Amygdala , 2002, Science.

[26]  M. Black,et al.  A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[27]  Bernard Bendriem,et al.  In vivo imaging of oligonucleotides with positron emission tomography , 1998, Nature Medicine.

[28]  Eva M Sevick-Muraca,et al.  Near-infrared fluorescence contrast-enhanced imaging with intensified charge-coupled device homodyne detection: measurement precision and accuracy. , 2003, Journal of biomedical optics.